DC therapy? Let the natural killer answer

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and tumor escape.

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume106
Issue number6
DOIs
StatePublished - Sep 15 2005
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'DC therapy? Let the natural killer answer'. Together they form a unique fingerprint.

Cite this